A recent study conducted by Liverpool University has shed light on the increasing risks associated with non-surgical cosmetic procedures such as botox and fillers. The research has revealed a concerning trend where the boundaries between surgical and non-surgical treatments have become blurred, emphasizing the urgent need for better regulation in the industry.
According to the study published in the British Medical Journal, nearly one million botox-like injections are administered annually in the UK, with reported side effects ranging from inflammation and anxiety to more serious complications like dry eyes, vision issues, and nerve damage. Dermal fillers, which account for a majority of non-surgical cosmetic procedures in the UK, have shown higher rates of complaints, including severe outcomes such as skin and tissue necrosis, blindness, and sepsis.
The Mirror’s campaign to Ban the Cosmetic Cowboys has drawn attention to the proliferation of unregulated clinics offering discounted and often risky cosmetic treatments performed by untrained staff. Instances of life-altering injuries and fatalities have been attributed to these rogue establishments, highlighting the pressing need for tighter regulations and oversight.
Dr. Danielle Griffiths, lead author of the study, emphasized the shift from cosmetic interventions being consumer concerns to posing significant patient safety and public health challenges. The research also revealed that a significant number of patients seeking medical attention for complications after non-surgical procedures required surgical interventions, with a majority of cases originating within the UK.
The study further pointed out the evolving nature of non-surgical procedures, which are increasingly becoming more invasive, blurring the traditional boundaries between surgical and non-surgical interventions. Dr. Griffiths highlighted the deceptive marketing tactics employed by some practitioners, exploiting idealized body images and leveraging celebrities and influencers to promote cosmetic procedures.
Complications arising from botox treatments were recommended to be reported to the Medicines and Healthcare Products Regulatory Agency (MHRA) yellow card scheme to improve monitoring and oversight. However, a significant portion of participants in the study reported being unaware of the reporting scheme, raising concerns about underreporting of complications. The study estimated that approximately 900,000 botox-like injections are administered in the UK each year.
In conclusion, Dr. Griffiths stressed the importance of all invasive cosmetic procedures being performed by trained healthcare professionals under strict regulatory oversight. Coordinated regulation across the UK is crucial to safeguard patient well-being and curb the rise of cosmetic tourism trends.
